Literature DB >> 6999010

Glucose kinetics in leprechaunism: accelerated fasting due to insulin resistance.

D M Bier, H Schedewie, J Larner, J Olefsky, A Rubenstein, R H Fiser, J W Craig, M J Elders.   

Abstract

Postprandial and postabsorptive glucose metabolism was studied in a 3-yr-old girl with leprechaunism by substrate and hormonal measurements and by quantifying hepatic glucose output during continuous infusion of D-[6-6-2H2]-glucose. Hepatic glucogen content and the activity of glycogen synthase and phosphorylase were also measured in the post-prandial state on a separate occasion. During the 4-h postprandial state, plasma glucose, alanine, lactate, beta-hydroxybutyrate, and glycerol were normal, as were hepatic glycogen, glycogen synthase, phosphorylase, and hepatic glucose output of 7.5 mg kg-1 min-1. Intravenous injection of glucagon (30 micrograms kg-1) caused an immediate almost 3-fold rise in glucose production consistent with brisk glycogenolysis. During the 8- to 12-h postabsorptive state, however, the patient had elevated levels of glycerol (330-508 microM) and beta-hydroxybutyrate (3291-3801 microM) and decreased levels of glucose 24-29 mg/dl) and alanine (121-135 microM) consistent with a much longer period of fasting in the normal child. Furthermore, hepatic glucose output was reduced to 3.9 mg kg-1 min-1, and iv glucagon injection failed to increase this rate; both of these observations are consistent with a hepatic state generally found only later in fasting in the normal child. From these observations we conclude that the hypoglycemia reported in the leprechaunism syndrome is due to an accelerated fasting state secondary to insulin resistance. As with long-fasted, glycogen-depleted normal children, gluconeogenesis alone is often not capable of adequately meeting the child's large noninsulin-dependent cerebral glucose requirements.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999010     DOI: 10.1210/jcem-51-5-988

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Qualitative abnormalities in insulin binding in a patient with extreme insulin resistance: decreased sensitivity to alterations in temperature and pH.

Authors:  S I Taylor; J Roth; R M Blizzard; M J Elders
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

2.  Hepatic ultrastructure in leprechaunism. Hepatic ultrastructural evidence suggesting a syndrome with defective hepatic glucose release.

Authors:  S I Roth; H K Schedewie; D M Bier; H H Conaway; J Olefsky; A Rubenstein; M J Elders
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

3.  Homozygosity for a new mutation (Ile119-->Met) in the insulin receptor gene in five sibs with familial insulin resistance.

Authors:  J Hone; D Accili; L I al-Gazali; G Lestringant; T Orban; S I Taylor
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

4.  Mechanisms of insulin resistance in cultured fibroblasts from a patient with leprechaunism: resistance to proteolytic activation of glycogen synthase by trypsin.

Authors:  J W Craig; J Larner; E F Locker; M J Elders
Journal:  Mol Cell Biochem       Date:  1985-03       Impact factor: 3.396

5.  Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance.

Authors:  S I Taylor; S Leventhal
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

6.  Leprechaunism: an inherited defect in a high-affinity insulin receptor.

Authors:  L J Elsas; F Endo; E Strumlauf; J Elders; J H Priest
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.